One of the ill effects of the continued prohibition on cannabis is the fact that governments are not overseeing the marijuana market. Instead of being at the forefront of regulating cannabis and cannabis products, they are busy jailing people for carrying and using cannabis. They are making it harder for patients to get access to lifesaving medical pot.
On top of losing money from taxes, governments also lose out on the chance to be able to properly regulate and control the market. This lack of regulation has caused the proliferation of mislabeled cannabis-related products online, specifically cannabidiol products.
Daniel A. Freedman, Anup D. Patel and other researchers at the University of Pennsylvania, RTI International, Veterans Affairs San Diego, Americans for Safe Access, John Hopkins University, and Palo Alto University went over the content of around seven dozen CBD products that they were able to purchase online and found that these products were mislabeled. Around 26% had less CBD than what is stated on the label, while 43% contained more CBD than what was advertised. This means that there is very poor standardization for online products, which is what most people have access to.
By product types, only 45% of oil based products were more or less accurate, that number goes down to 12.5% for vape liquids, and 25% for tincture.
More alarming, however, more than 1 out of every 5 products had THC in them. If you were trying to ingest CBD for your medical conditions, you might inadvertently get high because of the THC found in the product where there is supposed to be none. In fact, the researchers found that the THC levels in these products might intoxicate children.
The study suggests that the FDA warning letter published around two years ago is not enough to ensure standardization of online CBD retailers, which leads to their products being mislabeled.